Clinical study on hemoporfin PDT for infant facial port-wine stains

Yunjie Zhang1, Yuguang Yang1, Zhe Zhang1

  • 1Department of Dermatology of First Affiliated Hospital of PLA General Hospital, Beijing, 100048, China.

Insights

Hemoporfin photodynamic therapy (PDT) effectively treats infant facial port-wine stains (PWS), showing a 98% efficacy rate. Adverse reactions were minimal, indicating a safe and beneficial therapeutic option.

Area of Science:

  • Dermatology
  • Photomedicine
  • Pediatric Medicine

Background:

  • Infant facial port-wine stains (PWS) present a significant cosmetic and psychological concern.
  • Photodynamic therapy (PDT) offers a potential treatment modality for vascular lesions.

Purpose of the Study:

  • To evaluate the clinical efficacy and therapeutic response of Hemoporfin photodynamic therapy (PDT) for infant facial port-wine stains (PWS).

Main Methods:

  • 100 infant cases with facial PWS were treated using Hemoporfin PDT.
  • Treatment involved intravenous Hemippofen injection followed by irradiation with 532 nm LED green light.
  • Therapeutic response and clinical efficacy were monitored via a digital consulting platform.

Main Results:

  • An overall effective rate of 98% was achieved.
  • Common transient side effects included itching (85%), edema (100%), purpura-like changes (89%), and crusting (33%).
  • Minimal long-term adverse effects were observed, with hyperpigmentation and scarring in 2% of cases, and no systemic reactions.

Conclusions:

  • Hemoporfin PDT demonstrates high clinical efficacy and a favorable response rate for treating infant facial PWS.
  • The treatment is associated with generally mild and transient adverse reactions, making it a viable option for this pediatric population.
Abstract

Related Concept Videos

Muscles for Facial Expressions01:14

Muscles for Facial Expressions

The craniofacial muscles are a collection of approximately 20 thin skeletal muscles situated beneath the skin of the face and scalp. These muscles, primarily responsible for the vast array of human facial expressions, originate from the bones or fibrous structures of the skull and extend outwards to connect with the skin. While most skeletal muscles in the body are enveloped in thick fascia, facial muscles generally have a more delicate fascial covering, with the buccinator muscle being a...
4.9K
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
349
Facial Feedback Hypothesis01:24

Facial Feedback Hypothesis

Charles Darwin proposed that facial expressions are an evolutionary adaptation for communication. He argued that these expressions are not influenced by culture but are universal across species. For example, a snarling expression with exposed teeth signals a threat in many animals, including humans. Darwin also suggested that displaying an emotion can intensify the feeling. Smiling, for example, could enhance one's sense of happiness. This idea laid the foundation for understanding the role...
663
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
565
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
349
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
295